3-Chloro-2-(chloromethyl)pyridine hydrochloride, 95.0%, 100mg

1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

1-(5-Hydroxypyridin-3-yl)ethanone, 95%, 1g

3-(3,5-dimethylpiperidin-1-yl)propan-1-amine, 95.0%, 5g

O(1),O(3)-Bis(carboxymethyl)-O(2),O(4)-dimethyl-p-tert-butylcalix[4]arene, 97%, 100mg

(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride, 97%, 250mg

(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one, 96%, 100mg

Boc-Amcp-OH, 95.0%, 1g

Anti-6xHis Monoclonal Antibody (6A12)1vial

6-(4-Fluorophenyl)-3,4-dihydrothieno[3,2-d]-pyrimidin-4-one, 5g

Ethyl 4-chloro-6-(trifluoromethyl)nicotinate, 95.0%, 5g

2-Acetamido-5-bromotoluene, 95.0%, 5g

ethyl 3-bromo-7-chloroimidazo[1,2-a]pyridine-2-carboxylate, 100mg